C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
5.07
-0.01 (-0.20%)
Jul 4, 2025, 2:45 PM CST
SHE:000950 Revenue
C.Q. Pharmaceutical Holding had revenue of 20.61B CNY in the quarter ending March 31, 2025, with 5.03% growth. This brings the company's revenue in the last twelve months to 81.55B, up 4.02% year-over-year. In the year 2024, C.Q. Pharmaceutical Holding had annual revenue of 80.56B with 2.76% growth.
Revenue (ttm)
81.55B
Revenue Growth
+4.02%
P/S Ratio
0.11
Revenue / Employee
5.90M
Employees
13,820
Market Cap
8.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 80.56B | 2.16B | 2.76% |
Dec 31, 2023 | 78.40B | 10.57B | 15.58% |
Jan 1, 2023 | 67.83B | 5.31B | 8.49% |
Dec 31, 2021 | 62.52B | 17.30B | 38.26% |
Dec 31, 2020 | 45.22B | 11.38B | 33.61% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |